Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors
Background Activated prothrombin complex concentrate (aPCC) is indicated for bleed treatment and prevention in patients with hemophilia with inhibitors. The safety and tolerability of intravenous aPCC at a reduced volume and faster infusion rates were evaluated.
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Georg Thieme Verlag KG
2024-07-01
|
| Серія: | TH Open |
| Предмети: | |
| Онлайн доступ: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1787781 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|